Should You Invest In Regeneron Pharmaceuticals?

Get the facts about trading Regeneron Pharmaceuticals before you start. Discuss investment strategies, review market research, and get real-time updates

685,750 Regeneron Pharmaceuticals positions opened on eToro

Buy REGN
Sell REGN
REGNRegeneron Pharmaceuticals
577.81-8.44 ( -1.44%)
AAPL
AAPLApple
148.98 (0.29%)
buy
GOOG
GOOGAlphabet
2793.78 (1.33%)
buy
FB
FBFacebook
372.52 (0.72%)
buy
MSFT
MSFTMicrosoft
289.11 (-0.21%)
buy
TWTR
TWTRTwitter
68.73 (-4.18%)
buy

Regeneron Pharmaceuticals Inc. was founded in 1988 and is headquartered in Tarrytown, New York. It is a biopharmaceutical company focused on developing and commercializing medical solutions for eye diseases, high levels of cholesterol, asthma, atopic dermatitis, cancer, and other conditions. As of December 31, 2016, the Company has had six FDA-approved medicines, 16 product candidates in clinical development and 15 fully human monoclonal antibody product candidates. The company has collaboration and license agreements with Sanofi, Bayer, Teva and other companies. Learn more about this instrument and start trading.

Buy REGN Now
Sell REGN Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly

关注我们

微信公众号: e投睿eToro

eToro (Europe) Ltd., a Financial Services Company authorised and regulated by the Cyprus Securities Exchange Commission (CySEC) under the license # 109/10.

eToro AUS Capital Limited is authorised by the Australian Securities and Investments Commission (ASIC) to provide financial services under Australian Financial Services Licensce 491139.

eToro (UK) Ltd, a Financial Services Company Authorised and regulated by the Financial Conduct Authority (FCA) under the license FRN 583263.

Past performance is not an indication of future results.
General Risk Disclosure | Terms & Conditions

CFDs are leveraged products. Trading in CFDs related to foreign exchange, commodities,indices and other underlying variables, carries a high level of risk and can result in the loss of all of your investment. As such, CFDs may not be suitable for all investors. You should not invest money that you cannot afford to lose. Before deciding to trade, you should become aware of all the risks associated with CFD trading, and seek advice from an independent and suitably licensed financial advisor. Under no circumstances shall we have any liability to any person or entity for (a) any loss or damage in whole or part caused by, resulting from, or relating to any transactions related to CFDs or (b) any direct, indirect, special, consequential or incidental damages whatsoever. Trading with eToro by following and/or copying or replicating the trades of other traders involves a high level of risks, even when following and/or copying or replicating the top-performing traders. Such risks includes the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders and the overall risk associated in CFD trading or traders whose ultimate purpose or intention, or financial status may differ from yours. Past performance of an eToro Community Member is not a reliable indicator of his future performance. Content on eToro's social trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of eToro - Your Social Investment Network.

Start Trading
got it